Literature DB >> 7354475

Reversal of hypertrophic osteoarthropathy after chemotherapy for bronchogenic carcinoma.

W K Evans.   

Abstract

A patient with hypertrophic osteoarthropathy (HO) secondary to large cell anaplastic carcinoma of the lung was treated with combination chemotherapy (CAP-1). Systemic tumor symptoms resolved within 3 wk. Relief from the bone and articular symptoms of HO was noted after 3 months of treatment, coincident with a partial remission (greater than 50% tumor regression). Objective improvement in the radionuclide bone scan and radiographic periostitis was demonstrated after 6 months. Symptomatic improvement continued despite evidence of tumor progression after 10 months of treatment. Systemic chemotherapy should be considered in the management of symptomatic osteoarthropathy secondary to unresectable bronchogenic carcinoma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354475

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Role of immune complexes in hypertrophic osteoarthropathy and nonmetastatic polyarthritis.

Authors:  M S Awerbuch; P M Brooks
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

Review 2.  Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy.

Authors:  Sheila Nguyen; Mehrnaz Hojjati
Journal:  Clin Rheumatol       Date:  2010-10-09       Impact factor: 2.980

3.  Indomethacin therapy for hypertrophic pulmonary osteoarthropathy in patients with bronchogenic carcinoma.

Authors:  F W Leung; A J Williams; P Fan
Journal:  West J Med       Date:  1985-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.